Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Puneeth Iyengar

Showing results (101-110 of 178) with videos related to

Pageof 18
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 1, 2022
Avoiding Toxicity With Lung Radiation Therapy: An IASLC PerspectiveNicholas W Bucknell, José Belderbos, David A Palma, et al.
JAMA Network Open|December 9, 2025
Risk and Outcomes of Secondary Cancer Among Lung Cancer Survivors After Definitive TreatmentMatthew T McMillan, Orly Yariv, Sana Raoof, et al.
Advances in Radiation Oncology|September 23, 2022
T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung CancerEric J Hsu, Jameson T Mendel, Kristin A Ward, et al.
Journal of Applied Clinical Medical Physics|May 7, 2024
Beyond conventional bounds: Surpassing system limits for stereotactic ablative (SAbR) lung radiotherapy using CBCT-based adaptive planning systemYesenia Gonzalez, Justin Visak, Luke Overman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2020
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus documentYolande Lievens, Matthias Guckenberger, Daniel Gomez, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2024
Association of the time of day of chemoradiotherapy and durvalumab with tumor control in lung cancerMatthew T McMillan, Annemarie Shepherd, Alissa J Cooper, et al.
International Journal of Radiation Oncology, Biology, Physics|April 27, 2010
Radiation for Hodgkin's lymphoma in young female patients: a new technique to avoid the breasts and decrease the dose to the heartBouthaina S Dabaja, Neal C S Rebueno, Ali Mazloom, et al.
Translational Lung Cancer Research|October 24, 2025
Radiomic phenotypes of oligometastatic non-small cell lung cancerKevin M Boehm, Emily S Lebow, N Ari Wijetunga, et al.
JCO Global Oncology|August 21, 2025
Barriers to Immune Checkpoint Inhibitor Access for Patients With Cancer in Southeast Asia: Challenges and Policy ImplicationsAdrian E Go, Frances Dominique V Ho, Erin Jay G Feliciano, et al.
Journal of Clinical Medicine|February 13, 2026
Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) for Patients with Lung Tumors and Severe Pulmonary DiseaseKenneth D Westover, Ruiqi Li, Stetler Tanner, et al.
Pageof 18

Showing results (101-110 of 178) with videos related to

Sort By:
Pageof 18
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 1, 2022
Avoiding Toxicity With Lung Radiation Therapy: An IASLC PerspectiveNicholas W Bucknell, José Belderbos, David A Palma, et al.
JAMA Network Open|December 9, 2025
Risk and Outcomes of Secondary Cancer Among Lung Cancer Survivors After Definitive TreatmentMatthew T McMillan, Orly Yariv, Sana Raoof, et al.
Advances in Radiation Oncology|September 23, 2022
T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung CancerEric J Hsu, Jameson T Mendel, Kristin A Ward, et al.
Journal of Applied Clinical Medical Physics|May 7, 2024
Beyond conventional bounds: Surpassing system limits for stereotactic ablative (SAbR) lung radiotherapy using CBCT-based adaptive planning systemYesenia Gonzalez, Justin Visak, Luke Overman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2020
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus documentYolande Lievens, Matthias Guckenberger, Daniel Gomez, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2024
Association of the time of day of chemoradiotherapy and durvalumab with tumor control in lung cancerMatthew T McMillan, Annemarie Shepherd, Alissa J Cooper, et al.
International Journal of Radiation Oncology, Biology, Physics|April 27, 2010
Radiation for Hodgkin's lymphoma in young female patients: a new technique to avoid the breasts and decrease the dose to the heartBouthaina S Dabaja, Neal C S Rebueno, Ali Mazloom, et al.
Translational Lung Cancer Research|October 24, 2025
Radiomic phenotypes of oligometastatic non-small cell lung cancerKevin M Boehm, Emily S Lebow, N Ari Wijetunga, et al.
JCO Global Oncology|August 21, 2025
Barriers to Immune Checkpoint Inhibitor Access for Patients With Cancer in Southeast Asia: Challenges and Policy ImplicationsAdrian E Go, Frances Dominique V Ho, Erin Jay G Feliciano, et al.
Journal of Clinical Medicine|February 13, 2026
Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) for Patients with Lung Tumors and Severe Pulmonary DiseaseKenneth D Westover, Ruiqi Li, Stetler Tanner, et al.
Pageof 18